vs
BIOLIFE SOLUTIONS INC（BLFS）与Streamex Corp.（STEX）财务数据对比。点击上方公司名可切换其他公司
Streamex Corp.净利率更高（155840.0% vs 58.9%，领先155781.1%）。过去两年Streamex Corp.的营收复合增速更高（NaN% vs NaN%）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
BLFS vs STEX — 直观对比
营收规模更大
BLFS
是对方的-1878.5倍
$-10.0K
净利率更高
STEX
高出155781.1%
58.9%
两年增速更快
STEX
近两年复合增速
1.0%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $-10.0K |
| 净利润 | $11.1M | $-15.6M |
| 毛利率 | — | — |
| 营业利润率 | 7.2% | 61130.0% |
| 净利率 | 58.9% | 155840.0% |
| 营收同比 | 24.3% | — |
| 净利润同比 | -11.1% | -714.2% |
| 每股收益（稀释后） | $0.23 | $-0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSSTEX
| Q4 25 | $18.8M | — | ||
| Q3 25 | $28.1M | $-10.0K | ||
| Q2 25 | $25.4M | $13.0K | ||
| Q1 25 | $23.9M | — | ||
| Q4 24 | $15.1M | $13.0K | ||
| Q3 24 | $21.4M | $0 | ||
| Q2 24 | $19.7M | $13.0K | ||
| Q1 24 | $18.4M | $14.0K |
净利润BLFSSTEX
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | $-15.6M | ||
| Q2 25 | $-15.8M | $-20.4M | ||
| Q1 25 | $-448.0K | — | ||
| Q4 24 | $12.5M | $-1.1M | ||
| Q3 24 | $-1.7M | $-1.9M | ||
| Q2 24 | $-20.7M | $-3.9M | ||
| Q1 24 | $-10.2M | $-3.4M |
营业利润率BLFSSTEX
| Q4 25 | 7.2% | — | ||
| Q3 25 | -0.3% | 61130.0% | ||
| Q2 25 | -65.5% | -156653.8% | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | 3.6% | -9100.0% | ||
| Q3 24 | -2.0% | — | ||
| Q2 24 | -6.6% | -40707.7% | ||
| Q1 24 | -17.9% | -24550.0% |
净利率BLFSSTEX
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | 155840.0% | ||
| Q2 25 | -62.3% | -156707.7% | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | 82.5% | -8453.8% | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | -105.1% | -30115.4% | ||
| Q1 24 | -55.4% | -24300.0% |
每股收益（稀释后）BLFSSTEX
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.01 | $-0.47 | ||
| Q2 25 | $-0.33 | $-0.74 | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.27 | $0.03 | ||
| Q3 24 | $-0.04 | $-0.12 | ||
| Q2 24 | $-0.45 | $-0.30 | ||
| Q1 24 | $-0.22 | $-0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | — |
| 总债务越低越好 | $5.0M | — |
| 股东权益账面价值 | $371.9M | $-7.0M |
| 总资产 | $405.9M | $130.5M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资BLFSSTEX
| Q4 25 | $33.0M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $91.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $29.7M | — |
总债务BLFSSTEX
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
股东权益BLFSSTEX
| Q4 25 | $371.9M | — | ||
| Q3 25 | $353.7M | $-7.0M | ||
| Q2 25 | $347.2M | $-3.6M | ||
| Q1 25 | $352.6M | — | ||
| Q4 24 | $348.9M | $-1.5M | ||
| Q3 24 | $325.5M | $-405.0K | ||
| Q2 24 | $321.4M | $-6.0K | ||
| Q1 24 | $333.4M | $-4.3M |
总资产BLFSSTEX
| Q4 25 | $405.9M | — | ||
| Q3 25 | $392.1M | $130.5M | ||
| Q2 25 | $387.2M | $109.7M | ||
| Q1 25 | $395.1M | — | ||
| Q4 24 | $399.5M | $842.0K | ||
| Q3 24 | $381.7M | $1.4M | ||
| Q2 24 | $375.0M | $3.1M | ||
| Q1 24 | $401.6M | $1.6M |
负债/权益比BLFSSTEX
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $-5.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLFSSTEX
| Q4 25 | $4.9M | — | ||
| Q3 25 | $6.1M | $-5.0M | ||
| Q2 25 | $7.4M | $-1.3M | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $1.6M | $-474.0K | ||
| Q3 24 | $4.8M | $-1.5M | ||
| Q2 24 | $6.5M | $-1.5M | ||
| Q1 24 | $-4.5M | $-1.3M |
现金转化率BLFSSTEX
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
